Pubblicazioni Pier Giorgio Mastroberardino

  1. Milanese, C., Gabriels, S., Barnhoorn, S., Cerri, S., Ulusoy, A., Gornati, S.V., Wallace, D.F., Blandini, F., Di Monte, D.A., Subramaniam, V.N., Mastroberardino, P.G.
    Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease
    (2020) Cell Death and Differentiation. DOI: 10.1038/s41418-020-00698-4

  2. Milanese, C., Bombardieri, C.R., Sepe, S., Barnhoorn, S., Payán-Goméz, C., Caruso, D., Audano, M., Pedretti, S., Vermeij, W.P., Brandt, R.M.C., Gyenis, A., Wamelink, M.M., de Wit, A.S., Janssens, R.C., Leen, R., van Kuilenburg, A.B.P., Mitro, N., Hoeijmakers, J.H.J., Mastroberardino, P.G.
    DNA damage and transcription stress cause ATP-mediated redesign of metabolism and potentiation of anti-oxidant buffering
    (2019) Nature Communications, 10 (1), art. no. 4887. DOI: 10.1038/s41467-019-12640-5

  3. Milanese, C., Mastroberardino, P.G.
    A perspective on DNA damage-induced potentiation of the pentose phosphate shunt and reductive stress in chemoresistance
    (2020) Molecular and Cellular Oncology, 7 (3), art. no. 1733383. DOI: 10.1080/23723556.2020.1733383

  4. Milanese, C., Payán-Goméz, C., Mastroberardino, P.G.
    Cysteine oxidation and redox signaling in dopaminergic neurons physiology and in Parkinson's disease
    (2019) Current Opinion in Physiology, 9, pp. 73-78. DOI: 10.1016/j.cophys.2019.04.025

  5. Milanese, C., Payán-Goméz, C., Galvani, M., González, N.M., Tresini, M., Abdellah, S.N., van Roon-Mom, W.M.C., Figini, S., Marinus, J., van Hilten, J.J., Mastroberardino, P.G.
    Peripheral mitochondrial function correlates with clinical severity in idiopathic Parkinson’s disease
    (2019) Movement Disorders, 34 (8), pp. 1192-1202. DOI: 10.1002/mds.27723

  6. Milanese, C., Cerri, S., Ulusoy, A., Gornati, S.V., Plat, A., Gabriels, S., Blandini, F., Di Monte, D.A., Hoeijmakers, J.H., Mastroberardino, P.G.
    Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease
    (2018) Cell Death and Disease, 9 (8), art. no. 818. DOI: 10.1038/s41419-018-0848-7

  7. Milanese, C., Tapias, V., Gabriels, S., Cerri, S., Levandis, G., Blandini, F., Tresini, M., Shiva, S., Greenamyre, J.T., Gladwin, M.T., Mastroberardino, P.G.
    Mitochondrial Complex i Reversible S-Nitrosation Improves Bioenergetics and Is Protective in Parkinson's Disease
    (2018) Antioxidants and Redox Signaling, 28 (1), pp. 44-61. DOI: 10.1089/ars.2017.6992

  8. Sepe, S., Milanese, C., Gabriels, S., Derks, K.W.J., Payan-Gomez, C., van IJcken, W.F.J., Rijksen, Y.M.A., Nigg, A.L., Moreno, S., Cerri, S., Blandini, F., Hoeijmakers, J.H.J., Mastroberardino, P.G.
    Inefficient DNA Repair Is an Aging-Related Modifier of Parkinson's Disease
    (2016) Cell Reports, 15 (9), pp. 1866-1875. DOI: 10.1016/j.celrep.2016.04.071

  9. Sepe, S., Payan-Gomez, C., Milanese, C., Hoeijmakers, J.H., Mastroberardino, P.G.
    Nucleotide excision repair in chronic neurodegenerative diseases
    (2013) DNA Repair, 12 (8), pp. 568-577. DOI: 10.1016/j.dnarep.2013.04.009

  10. Horowitz, M.P., Milanese, C., Di Maio, R., Hu, X., Montero, L.M., Sanders, L.H., Tapias, V., Sepe, S., Van Cappellen, W.A., Burton, E.A., Greenamyre, J.T., Mastroberardino, P.G.
    Single-cell redox imaging demonstrates a distinctive response of dopaminergic neurons to oxidative insults
    (2011) Antioxidants and Redox Signaling, 15 (4), pp. 855-871. DOI: 10.1089/ars.2010.3629